© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Xvivo Perfusion AB (publ) (XVIPF) stock surged +1.26%, trading at $23.52 on OTC, up from the previous close of $23.52. The stock opened at $23.52, fluctuating between $23.52 and $23.52 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 05, 2026 | 23.79 | 23.79 | 23.52 | 23.52 | 519 |
| Feb 03, 2026 | 23.85 | 23.85 | 23.85 | 23.85 | 250 |
| Feb 02, 2026 | 24.15 | 24.15 | 24.15 | 24.15 | 100 |
| Jan 30, 2026 | 26.75 | 26.75 | 25.49 | 25.49 | 250 |
| Jan 27, 2026 | 23.80 | 24.77 | 23.80 | 24.77 | 400 |
| Jan 21, 2026 | 23.25 | 23.25 | 23.25 | 23.25 | 100 |
| Jan 20, 2026 | 23.43 | 23.43 | 23.43 | 23.43 | 425 |
| Jan 16, 2026 | 23.05 | 23.05 | 23.05 | 23.05 | 100 |
| Jan 07, 2026 | 20.27 | 20.27 | 20.27 | 20.27 | 250 |
| Dec 29, 2025 | 20.70 | 20.70 | 20.70 | 20.70 | 500 |
| Dec 22, 2025 | 20.11 | 20.11 | 20.11 | 20.11 | 190 |
| Dec 11, 2025 | 19.40 | 19.40 | 19.40 | 19.40 | 319 |
| Dec 08, 2025 | 19.64 | 19.64 | 19.64 | 19.64 | 1K |
| Dec 04, 2025 | 18.60 | 18.60 | 18.60 | 18.60 | 200 |
| Nov 26, 2025 | 19.70 | 19.70 | 19.70 | 19.70 | 153 |
| Nov 14, 2025 | 17.45 | 17.45 | 17.45 | 17.45 | 1 |
| Nov 06, 2025 | 18.00 | 18.00 | 18.00 | 18.00 | 1.39K |
| Nov 04, 2025 | 18.86 | 18.86 | 18.86 | 18.86 | 530 |
| Oct 14, 2025 | 16.98 | 16.98 | 16.98 | 16.98 | 250 |
| Sep 18, 2025 | 19.00 | 19.00 | 19.00 | 19.00 | 0 |
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
| Employees | 193 |
| Beta | 1.89 |
| Sales or Revenue | $822.42M |
| 5Y Sales Change% | 1.795% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |